Article Versions Notes

Smith JW, Ng DK, Alvarez CS, Egner PA, Burke SM, Chen J-G, Kensler TW, Koshiol J, Rivera-Andrade A, Kroker-Lobos MF, et al. Assessing the Validity of Normalizing Aflatoxin B₁-Lysine Albumin Adduct Biomarker Measurements to Total Serum Albumin Concentration across Multiple Human Population Studies. Toxins. 2022; 14(3):162. https://doi.org/10.3390/toxins14030162

Smith, Joshua W., Derek K. Ng, Christian S. Alvarez, Patricia A. Egner, Sean M. Burke, Jian-Guo Chen, Thomas W. Kensler, Jill Koshiol, Alvaro Rivera-Andrade, María F. Kroker-Lobos, and et al. 2022. "Assessing the Validity of Normalizing Aflatoxin B₁-Lysine Albumin Adduct Biomarker Measurements to Total Serum Albumin Concentration across Multiple Human Population Studies" Toxins 14, no. 3: 162. https://doi.org/10.3390/toxins14030162

Smith, J. W., Ng, D. K., Alvarez, C. S., Egner, P. A., Burke, S. M., Chen, J. -G., Kensler, T. W., Koshiol, J., Rivera-Andrade, A., Kroker-Lobos, M. F., Ramírez-Zea, M., McGlynn, K. A., & Groopman, J. D. (2022). Assessing the Validity of Normalizing Aflatoxin B₁-Lysine Albumin Adduct Biomarker Measurements to Total Serum Albumin Concentration across Multiple Human Population Studies. Toxins, 14(3), 162. https://doi.org/10.3390/toxins14030162